Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Lohmann, Michael ^a   Walenda, Gudrun ^a   Hemeda, Hatim ^a   Joussen, Sylvia ^a   Drescher, Wolf ^b   Jockenhoevel, Stefan ^a   Hutschenreuter, Gabriele ^b   Zenke, Martin ^a,b   Wagner, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BETA GALACTOSIDASE; CALCITRIOL; ESTRADIOL; LEPTIN; PARATHYROID HORMONE; PLATELET DERIVED GROWTH FACTOR AB; SENESCENCE ASSOCIATED BETA GALACTOSIDASE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADULT; AGE; AGED; ARTICLE; BLOOD DONOR; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; FEEDBACK SYSTEM; FEMALE; FIBROBLAST; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL; PROTEIN BLOOD LEVEL; THROMBOCYTE; THROMBOCYTE COUNT;

ADULT; AGE FACTORS; AGED; AGING; BETA-GALACTOSIDASE; BLOOD PLATELETS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOGENESIS; TISSUE DONORS; YOUNG ADULT;

EID: 84861469048     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037839     Document Type: Article

References (61)

1. Ho AD, Wagner W, Mahlknecht U, (2005) Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine. EMBO Rep 6: 35-38.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
3. Caplan AI, (1991) Mesenchymal stem cells. J Orthop Res 9: 641-650.
4. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, et al. (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395.
5. Ho AD, Wagner W, Franke W, (2008) Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 10: 320-330.
6. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
7. Caplan AI, Dennis JE, (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98: 1076-1084.
8. Wagner W, Ho AD, (2007) Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev 3: 239-248.
9. Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, et al. (2007) No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92: 1208-1215.
10. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, et al. (2004) Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9: 747-756.
11. Stute N, Holtz K, Bubenheim M, Lange C, Blake F, et al. (2004) Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32: 1212-1225.
12. Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, et al. (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27: 2331-2341.
13. Goedecke A, Wobus M, Krech M, Munch N, Richter K, et al. (2011) Differential effect of platelet-rich plasma and fetal calf serum on bone marrow-derived human mesenchymal stromal cells expanded in vitro. J Tissue Eng Regen Med 5: 648-654.
14. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, et al. (2005) Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205: 228-236.
15. Muller I, Kordowich S, Holzwarth C, Spano C, Isensee G, et al. (2006) Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8: 437-444.
16. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, et al. (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
17. Doumit ME, Cook DR, Merkel RA, (1993) Fibroblast growth factor, epidermal growth factor, insulin-like growth factors, and platelet-derived growth factor-BB stimulate proliferation of clonally derived porcine myogenic satellite cells. J Cell Physiol 157: 326-332.
18. Ng F, Boucher S, Koh S, Sastry KS, Chase L, et al. (2008) PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112: 295-307.
19. Hwang DL, Latus LJ, Lev-Ran A, (1992) Effects of platelet-contained growth factors (PDGF, EGF, IGF-I, and TGF-beta) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp Cell Res 200: 358-360.
20. Cholewa D, Stiehl T, Schellenberg A, Bokermann G, Joussen S, et al. (2011) Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant 20: 1409-1422.
21. Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, et al. (2010) Comparison of Individual Platelet Lysates for Isolation of Human Mesenchymal Stromal Cells. Cytotherapy 12: 888-898.
22. Schallmoser K, Strunk D, (2009) Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures. J Vis Exp 32: 1523.
23. Carrel A, Ebeling AH, (1921) Age and multiplication of fibroblasts. J Exp Med 34: 599-623.
24. Parker RC, (1931) Human serum, age and multiplication of homologous fibroblasts. Science 74: 181-182.
25. Auer D, Hubalek M, Fleischer M, Roessler J, Daxenbichler G, (2008) The growth-promoting action of individual women's sera on mammary carcinoma cells. Anticancer Res 28: 2213-2217.
26. Zhang DY, Wang HJ, Tan YZ, (2011) Wnt/beta-Catenin Signaling Induces the Aging of Mesenchymal Stem Cells through the DNA Damage Response and the p53/p21 Pathway. PLoS ONE 6: e21397.
27. George T, Velloso CP, Alsharidah M, Lazarus NR, Harridge SD, (2010) Sera from young and older humans equally sustain proliferation and differentiation of human myoblasts. Exp Gerontol 45: 875-881.
28. Abdallah BM, Haack-Sorensen M, Fink T, Kassem M, (2006) Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 39: 181-188.
29. Kondo H, Nomaguchi TA, Sakurai Y, Yonezawa Y, Kaji K, et al. (1988) Effects of serum from human subjects of various ages on proliferation of human lung and skin fibroblasts. Exp Cell Res 178: 287-295.
30. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, et al. (2008) Replicative Senescence of Mesenchymal Stem Cells- a Continuous and Organized Process. PLoS ONE 5: e2213.
31. Rodriguez JP, Astudillo P, Rios S, Pino AM, (2008) Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther 3: 208-218.
32. Wagner W, Bork S, Horn P, Krunic D, Walenda T, et al. (2009) Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS ONE 4: e5846.
33. Schellenberg A, Lin Q, Schueler H, Koch C, Joussen S, et al. (2011) Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY) 3: 873-888.
34. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
35. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O, (2009) Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4: 1798-1806.
36. Koch C, Suschek CV, Lin Q, Bork S, Goergens M, et al. (2011) Specific Age-associated DNA Methylation Changes in Human Dermal Fibroblasts. PLoS ONE 6: e16679.
37. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, et al. (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764.
38. Wagner W, Bork S, Lepperdinger G, Joussen S, Ma N, et al. (2010) How to track cellular aging of mesenchymal stromal cells. Aging (Albany NY) 2: 224-230.
39. Wagner W, Ho AD, Zenke M, (2010) Different Facets of Aging in Human Mesenchymal Stem Cells. Tissue Eng Part B Rev 16: 445-453.
40. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, et al. (2008) Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 7: 335-343.
41. Bernardo ME, Cometa AM, Pagliara D, Vinti L, Rossi F, et al. (2011) Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol 24: 73-81.
42. Li Y, Yu X, Lin S, Li X, Zhang S, et al. (2007) Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun 356: 780-784.
43. Ogino Y, Ayukawa Y, Kukita T, Koyano K, (2006) The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101: 724-729.
44. Huang Q, Wang YD, Wu T, Jiang S, Hu YL, et al. (2009) Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells. Chin Med J (Engl) 122: 83-87.
45. Tokunaga A, Oya T, Ishii Y, Motomura H, Nakamura C, et al. (2008) PDGF receptor beta is a potent regulator of mesenchymal stromal cell function. J Bone Miner Res 23: 1519-1528.
46. Wirz S, Dietrich M, Flanagan TC, Bokermann G, Wagner W, et al. (2011) Influence of Platelet-Derived Growth Factor-AB on Tissue Development in Autologous Platelet-Rich Plasma Gels. Tissue Eng Part A 17: 1891-1899.
47. Kumar A, Salimath BP, Stark GB, Finkenzeller G, (2010) Platelet-derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A 16: 983-993.
48. Chieregato K, Castegnaro S, Madeo D, Astori G, Pegoraro M, et al. (2011) Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue. Cytotherapy 13: 933-943.
49. Walsh S, Jefferiss CM, Stewart K, Beresford JN, (2003) IGF-I does not affect the proliferation or early osteogenic differentiation of human marrow stromal cells. Bone 33: 80-89.
50. Schellenberg A, Stiehl T, Horn P, Joussen S, Pallua N, et al. (2012) Population Dynamics of Mesenchymal Stromal Cells during Culture Expansion. Cytotherapy 14: 401-411.
51. Schallmoser K, Rohde E, Bartmann C, Obenauf AC, Reinisch A, et al. (2009) Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Biomed Mater Eng 19: 271-276.
52. Fekete N, Gadelorge M, Furst D, Maurer C, Dausend J, et al. (2012) Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 14: 540-554.
53. Stenderup K, Justesen J, Clausen C, Kassem M, (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33: 919-926.
54. Schneider EL, Mitsui Y, (1976) The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci U S A 73: 3584-3588.
55. Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, et al. (2006) Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97: 744-754.
56. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC, (1998) Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A 95: 10614-10619.
57. Bissels U, Bosio A, Wagner W, (2012) MicroRNAs are shaping the hematopoietic landscape. Haematologica 97: 160-167.
58. Bork S, Pfister S, Witt H, Horn P, Korn B, et al. (2010) DNA Methylation Pattern Changes upon Long-Term Culture and Aging of Human Mesenchymal Stromal Cells. Aging Cell 9: 54-63.
59. Koch CM, Joussen S, Schellenberg A, Lin Q, Zenke M, et al. (2012) Monitoring of Cellular Senescence by DNA-Methylation at Specific CpG sites. Aging Cell. 11: 366-369.
60. Bonin M, Stolzel F, Goedecke A, Richter K, Wuschek N, et al. (2009) Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43: 245-251.
61. Lucchini G, Introna M, Dander E, Rovelli A, Balduzzi A, et al. (2010) Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population. Biol Blood Marrow Transplant 16: 1293-1301.